Mesh.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Mesh.i » - entrée « B-Lymphocytes »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
B-Lymphocyte Subsets < B-Lymphocytes < B-Lymphocytes, Regulatory  Facettes :

List of bibliographic references indexed by B-Lymphocytes

Number of relevant bibliographic references: 24.
[0-20] [0 - 20][0 - 24][20-23][20-40]
Ident.Authors (with country if any)Title
000B53 (2019) Diego Strianese [Arabie saoudite] ; Francesca Rossi [Italie]Interruption of autoimmunity for thyroid eye disease: B-cell and T-cell strategy.
001423 (2018) Shingo Nakayamada [Japon] ; Satoshi Kubo [Japon] ; Maiko Yoshikawa [Japon] ; Yusuke Miyazaki [Japon] ; Naoki Yunoue [Japon] ; Shigeru Iwata [Japon] ; Ippei Miyagawa [Japon] ; Shintaro Hirata [Japon] ; Kazuhisa Nakano [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon]Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis.
001480 (2018) Takayuki Yamamoto [États-Unis] ; Qi Li [République populaire de Chine] ; Hidetaka Hara [États-Unis] ; Liaoran Wang [République populaire de Chine] ; Hongmin Zhou [République populaire de Chine] ; Juan Li [République populaire de Chine] ; Devin E. Eckhoff [États-Unis] ; A. Joseph Tector [États-Unis] ; Edwin C. Klein [États-Unis] ; Ray Lovingood [États-Unis] ; Mohamed Ezzelarab [États-Unis] ; David Ayares [États-Unis] ; Yi Wang [République populaire de Chine] ; David K C. Cooper [États-Unis] ; Hayato Iwase [États-Unis]B cell phenotypes in baboons with pig artery patch grafts receiving conventional immunosuppressive therapy.
001493 (2018) Sarah Fleischer [Allemagne] ; Stefanie Ries [Allemagne] ; Ping Shen [Allemagne] ; Alix Lheritier [France] ; Frédéric Cazals [France] ; Gerd R. Burmester [Allemagne] ; Thomas Dörner [Allemagne] ; Simon Fillatreau [Allemagne]Anti-interleukin-6 signalling therapy rebalances the disrupted cytokine production of B cells from patients with active rheumatoid arthritis.
001661 (2017) Olafur Sveinsson [Suède] ; Mathias Granqvist [Suède] ; Yngve Forslin [Suède] ; Kaj Blennow [Suède] ; Henrik Zetterberg [Royaume-Uni] ; Fredrik Piehl [Suède]Successful combined targeting of B- and plasma cells in treatment refractory anti-NMDAR encephalitis.
001C43 (2016) Feng-Ting Liu [République populaire de Chine] ; Li Jia [Royaume-Uni] ; Ping Wang [République populaire de Chine] ; Timothy Farren [Royaume-Uni] ; Hong Li [Royaume-Uni] ; Xishan Hao [République populaire de Chine] ; Samir G. Agrawal [Royaume-Uni]CD126 and Targeted Therapy with Tocilizumab in Chronic Lymphocytic Leukemia.
001F12 (2015) Martin Aringer [Allemagne] ; Josef S. SmolenSafety of off-label biologicals in systemic lupus erythematosus.
001F60 (2015) M. Salvi [Italie] ; I. Campi [Italie]Medical Treatment of Graves' Orbitopathy.
002068 (2015) Konstantia-Maria Chavele [Royaume-Uni] ; Eve Merry [Royaume-Uni] ; Michael R. Ehrenstein [Royaume-Uni]Cutting edge: circulating plasmablasts induce the differentiation of human T follicular helper cells via IL-6 production.
002098 (2015) Zafar Mahmood [Allemagne] ; Khalid Muhammad [Allemagne] ; Marc Schmalzing [Allemagne] ; Petra Roll [Allemagne] ; Thomas Dörner [Allemagne] ; Hans-Peter Tony [Allemagne]CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis.
002502 (2014) Markus Krumbholz [Allemagne] ; Edgar MeinlB cells in MS and NMO: pathogenesis and therapy.
002642 (2013) M. Fleck ; B. Hellmich[Vasculitis].
002750 (2013) Gustavo Carbone [États-Unis] ; Augusta Wilson ; Sean A. Diehl ; Janice Bunn ; Sheldon M. Cooper ; Mercedes RinconInterleukin-6 receptor blockade selectively reduces IL-21 production by CD4 T cells and IgG4 autoantibodies in rheumatoid arthritis.
003480 (2012) Karel Pavelka [République tchèque] ; Arthur F. Kavanaugh ; Andrea Rubbert-Roth ; Gianfranco FerraccioliOptimizing outcomes in rheumatoid arthritis patients with inadequate responses to disease-modifying anti-rheumatic drugs.
003536 (2012) Takashi Yamamura ; Sachiko MiyakeB-cell-directed therapy: which B cells should be targeted and how?
003911 (2011) Maya H. Buch [Royaume-Uni] ; Paul EmeryNew therapies in the management of rheumatoid arthritis.
003931 (2011) Petra Roll [Allemagne] ; Khalid Muhammad ; Mathias Schumann ; Stefan Kleinert ; Hermann Einsele ; Thomas Dörner ; Hans-Peter TonyIn vivo effects of the anti-interleukin-6 receptor inhibitor tocilizumab on the B cell compartment.
003964 (2011) Stanley C. Jordan [États-Unis] ; Joseph Kahwaji ; Mieko Toyoda ; Ashley VoB-cell immunotherapeutics: emerging roles in solid organ transplantation.
003A72 (2011) Kjell Tullus [Royaume-Uni]New developments in the treatment of systemic lupus erythematosus
003E78 (2009) Taichi Hayashi ; Takayuki Sumida[Targeted therapies including monoclonal antibodies for connective tissue diseases].
004060 (2008) A A Aran [États-Unis] ; C. PuttermanTreatment of lupus nephritis: facing the era of immunotherapy.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "B-Lymphocytes" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "B-Lymphocytes" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    B-Lymphocytes
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021